Tower Research Capital (TRC)’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,329
| Closed | -$143K | – | 6507 |
|
|
2023
Q1 | $143K | Buy |
1,329
+1,069
| +411% | +$115K | ﹤0.01% | 1571 |
|
|
2022
Q4 | $29K | Sell |
260
-4,680
| -95% | -$522K | ﹤0.01% | 2797 |
|
|
2022
Q3 | $291K | Buy |
4,940
+3,908
| +379% | +$230K | ﹤0.01% | 1574 |
|
|
2022
Q2 | $29K | Sell |
1,032
-531
| -34% | -$14.9K | ﹤0.01% | 3428 |
|
|
2022
Q1 | $59K | Buy |
1,563
+1,115
| +249% | +$42.1K | ﹤0.01% | 2605 |
|
|
2021
Q4 | $18K | Buy |
448
+42
| +10% | +$1.69K | ﹤0.01% | 3821 |
|
|
2021
Q3 | $10K | Sell |
406
-593
| -59% | -$14.6K | ﹤0.01% | 4373 |
|
|
2021
Q2 | $25K | Buy |
+999
| New | +$25K | ﹤0.01% | 3705 |
|